Skip to main content
James Thompson, MD, Oncology, Buffalo, NY

James E Thompson MD M.S. (He/Him)

Hematologic Oncology


Attending Physician

Join to View Full Profile
  • Elm And Carlton StBuffalo, NY 14263

  • Phone+1 716-845-7110

Dr. Thompson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Northwestern University
    Northwestern UniversityMS, Medical Informatics, 2013 - 2018
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2000 - 2003
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 2001
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1997

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2008 - 2026
  • PA State Medical License
    PA State Medical License 1998 - 2010
  • Hematology
    American Board of Internal Medicine Hematology
  • Clinical Informatics
    American Board of Preventive Medicine Clinical Informatics

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) Study
    James E. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid...
    James E. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Outcomes of AML Patients Treated with Gemtuzumab-Ozogamicin Based Therapies: A Cue to Optimal Chemotherapy Backbone
    James E. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Press Mentions

  • Buffalo Spree Names Record 143 Roswell Park Physicians as Top Doctors for 2025
    Buffalo Spree Names Record 143 Roswell Park Physicians as Top Doctors for 2025December 30th, 2024
  • Roswell Park Licenses Rapid, Comprehensive Blood Test to Agilent, a Global Leader in the Life Sciences Market
    Roswell Park Licenses Rapid, Comprehensive Blood Test to Agilent, a Global Leader in the Life Sciences MarketOctober 20th, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: